Full Press Release Details
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
INTERIM CONDENSED FINANCIAL STATEMENTS
_______________________
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
| Page | ||
| Interim condensed statements of financial position | 1-2 | |
| Interim condensed statements of comprehensive loss | 3 | |
| Interim condensed statements of changes in shareholders' equity | 4 | |
| Interim condensed statements of cash flows | 5 | |
| Notes to the unaudited interim condensed financial statements | 6-16 |
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
UNAUDITED INTERIM CONDENSED STATEMENTS OF FINANCIAL
(U.S. dollars in thousands)
| June 30, | December 31, | |||||||
| 2023 | 2022 | |||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | 3,324 | 6,783 | ||||||
| Deposits | 5,643 | 7,120 | ||||||
| Other current assets | 356 | 591 | ||||||
| Total current assets | 9,323 | 14,494 | ||||||
| Non-Current Assets: | ||||||||
| Right of use assets, net | 967 | 1,107 | ||||||
| Property, plant and equipment, net | 550 | 411 | ||||||
| Total non-current assets | 1,517 | 1,518 | ||||||
| Total Assets | 10,840 | 16,012 |
The accompanying notes are an integral part of the financial statements.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
UNAUDITED INTERIM CONDENSED STATEMENTS OF FINANCIAL
(U.S. dollars in thousands)
| June 30, | December 31, | |||||||||||
| Note | 2023 | 2022 | ||||||||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||||||
| Current Liabilities: | ||||||||||||
| Trade accounts payable | 149 | 150 | ||||||||||
| Other accounts payable | 3 | 1,372 | 1,217 | |||||||||
| Lease liabilities | 309 | 329 | ||||||||||
| Financial liabilities at fair market value | 4 | 438 | 368 | |||||||||
| Total current liabilities | 2,268 | 2,064 | ||||||||||
| Non-Current Liabilities: | ||||||||||||
| Lease liabilities | 588 | 728 | ||||||||||
| Loan from the Israeli Innovation Authority | 432 | 398 | ||||||||||
| Total non- current liabilities | 1,020 | 1,126 | ||||||||||
| Shareholders' Equity: | ||||||||||||
| Share capital and additional paid-in capital | 2 | 54,831 | 53,814 | |||||||||
| Foreign exchange reserve | ( 2,360 | ) | ( 1,928 | ) | ||||||||
| Accumulated deficit | ( 44,919 | ) | ( 39,064 | ) | ||||||||
| Total equity | 7,552 | 12,822 | ||||||||||
| Total Liabilities and Shareholders' Equity | 10,840 | 16,012 |
| September 27, 2023 | ||||
| Yafit Tehila Chief Financial Officer | Dagi Ben-Noon Chief Executive Officer | Date of approval of financial statements |
The accompanying notes are an integral part of the financial statements.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
UNAUDITED INTERIM CONDENSED STATEMENTS OF COMPREHENSIVE
(U.S. dollars in thousands)
| Six months ended June 30, | Six months ended June 30, | |||||||
| 2023 | 2022 | |||||||
| Research and development expenses | 3,830 | 4,294 | ||||||
| Sales and marketing expenses | 401 | 777 | ||||||
| General and administrative expenses | 2,104 | 2,936 | ||||||
| Operating loss | 6,335 | 8,007 | ||||||
| Finance income | ( 652 | ) | ( 4,558 | ) | ||||
| Finance expense | 172 | 24 | ||||||
| Loss before tax | 5,855 | 3,473 | ||||||
| Taxes on income | - | - | ||||||
| Total net loss | 5,855 | 3,473 | ||||||
| Other comprehensive loss, net of tax: | ||||||||
| Items that will not be reclassified to profit or loss: | ||||||||
| Exchange losses arising on translation to presentation currency | ( 432 | ) | ( 2,235 | ) | ||||
| Total comprehensive loss | 6,287 | 5,708 | ||||||
| Weighted average number of ordinary shares | 11,546,570 | 10,475,392 | ||||||
| Basic and diluted loss per share | ( 0.54 | ) | ( 0.54 | ) |
The accompanying notes are an integral part of the financial statements.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
UNAUDITED INTERIM CONDENSED STATEMENTS OF CHANGES
IN SHAREHOLDERS' EQUITY
(U.S. dollars in thousands)
For the six months ended June 30, 2023:
| Ordinary Share Capital | ||||||||||||||||||||
| Number of shares | Share Capital and Additional Paid in Capital | Adjustments arising from translating financial operation | Accumulated deficit | Total | ||||||||||||||||
| Balance at January 1, 2023: | 11,338,940 | 53,814 | ( 1,928 | ) | ( 39,064 | ) | 12,822 | |||||||||||||
| Changes during the period: | ||||||||||||||||||||
| Net loss | - | - | ( 5,855 | ) | ( 5,855 | ) | ||||||||||||||
| Other comprehensive loss | - | ( 432 | ) | - | ( 432 | ) | ||||||||||||||
| Total comprehensive loss | - | ( 432 | ) | ( 5,855 | ) | ( 6,287 | ) | |||||||||||||
| RSUs vesting | 654,359 | - | - | - | - | |||||||||||||||
| Share-based compensation | - | 1,017 | - | - | 1,017 | |||||||||||||||
| Balance at June 30, 2023 | 11,993,299 | 54,831 | ( 2,360 | ) | ( 44,919 | ) | 7,552 |
For the six months ended June 30, 2022:
| Ordinary Share Capital | ||||||||||||||||||||
| Number of shares | Share Capital and Additional Paid in Capital | Adjustments arising from translating financial operation | Accumulated deficit | Total | ||||||||||||||||
| Balance at January 1, 2022: | 10,091,706 | 48,935 | 210 | ( 28,791 | ) | 20,354 | ||||||||||||||
| Changes during the period: | ||||||||||||||||||||
| Net loss | - | - | - | ( 3,473 | ) | ( 3,473 | ) | |||||||||||||
| Other comprehensive loss | - | - | ( 2,235 | ) | - | ( 2,235 | ) | |||||||||||||
| Total comprehensive loss | - | - | ( 2,235 | ) | ( 3,473 | ) | ( 5,708 | ) | ||||||||||||
| Share based compensation to exercise | 2,721 | - | - | - | - | |||||||||||||||
| RSUs vesting | 749,242 | - | - | - | - | |||||||||||||||
| Share base compensation | - | 3,107 | - | - | 3,107 | |||||||||||||||
| Balance at June 30, 2022 | 10,843,669 | 52,042 | ( 2,025 | ) | ( 32,264 | ) | 17,753 |
The accompanying notes are an integral part
of the financial statements.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
UNAUDITED INTERIM CONDENSED STATEMENTS OF CASH
(U.S. dollars in thousands)
| Six months ended June 30, 2023 | Six months ended June 30, 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net loss | ( 5,855 | ) | ( 3,473 | ) | ||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
| Depreciation | 193 | 98 | ||||||
| Increase (decrease) in other current assets | 219 | 400 | ||||||
| Increase (decrease) in trade accounts payable | 6 | ( 35 | ) | |||||
| Increase (decrease) in other accounts payable | 221 | 503 | ||||||
| Share based compensation | 1,017 | 3,107 | ||||||
| Change in fair market value of financial liabilities at fair market value | 90 | ( 2,586 | ) | |||||
| Financial income | ( 620 | ) | ( 27 | ) | ||||
| Financial expenses | 78 | 51 | ||||||
| Net cash used in operating activities | ( 4,651 | ) | ( 1,962 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchase of property, plant and equipment | ( 206 | ) | ( 55 | ) | ||||
| Change in deposits, net | 1,934 | ( 4,994 | ) | |||||
| Change in restricted deposits | ( 7 | ) | 42 | |||||
| Net cash provided investing activities | 1,721 | ( 5,007 | ) | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Principal paid on lease liabilities | ( 196 | ) | ( 155 | ) | ||||
| Net cash provided financing activities | ( 196 | ) | ( 155 | ) | ||||
| Net increase in cash and cash equivalents | ( 3,126 | ) | ( 7,124 | ) | ||||
| Cash and cash equivalents at the beginning of the period | 6,783 | 23,749 | ||||||
| Effects of exchange rate changes on cash and cash equivalents | ( 333 | ) | ( 2,471 | ) | ||||
| Cash and cash equivalents at the end of the period | 3,324 | 14,154 |
The accompanying notes are an integral part of the financial statements.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL
(U.S. dollars in thousands)
The Company operates in the medical
technology industry in the field of respiratory support technology. It is engaged in the research, development, manufacturing-related
activities, and go-to-market activities of proprietary products and technologies. The Company is developing the following products:
(*) The INSPIRA ART500 (Augmented
Respiratory Technology), a respiratory support technology geared towards utilizing direct blood oxygenation to boost patient saturation
levels within minutes while the patient is awake and spontaneously breathing. The aim is to reduce the need for invasive mechanical ventilation,
with the potential to reduce risks, complications and high costs.
(*) The HYLA blood sensor, a non-invasive
optical blood sensor designed to perform real-time and continuous blood measurements, potentially minimizing the need to take actual
blood samples from patients.
(*) The INSPIRA ART100, an advanced
form of life support system, better known by the medical industry as a cardiopulmonary bypass system, is being designed for use in surgical
procedures requiring cardiopulmonary bypass for six hours or less.
The Company's products are in
the development stage. The INSPIRA ART100 device and the INSPIRA ART500 have not yet been tested or used in humans and the Company's
products have not been approved by the U.S. Food and Drug Administration.
On July 16, 2021, the Company completed
its initial public offering (the "IPO") on the Nasdaq Capital Market, whereby the Company sold 2,909,091 ordinary shares,
no par value (the "Ordinary Shares") and 3,345,455 tradable warrants (inclusive of 436,364 tradable warrants pursuant to
the exercise of an overallotment option granted to the underwriters). The aggregate proceeds received by the Company from the IPO were
approximately $14,490, after deducting underwriting discounts and commissions and additional offering costs totaling approximately $1,543.
On July 16, 2021, following the closing of the IPO, the Company issued 2,113,905 Ordinary Shares and 1,149,582 non-tradable warrants
to investors and 16,587 non-tradeable warrants to brokers in connection with the conversion of Company's previously issued financial
liabilities at fair market value.
In October 2021, investors exercised
tradable warrants to purchase 1,705,000 Ordinary Shares of the Company. The total proceeds received by the Company from this exercise
were $9,377. The Company paid fees of 7%, amounting to $656, according to the terms of a contract with a promoter in connection with
the IPO for which the Company recorded a financial liability.
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL
(U.S. dollars in thousands)
NOTE 1 - GENERAL (Cont.):
On April 4, 2023, the Company, entered
into a sales agreement with Roth Capital Partners, LLC, as sales agent (the "Sales Agent"), pursuant to which the Company
may offer and sell, from time to time, through the Sales Agent, the Company's Ordinary Shares, no par value per share (the "ATM").
The Ordinary Shares shall be offered and sold pursuant to the Company's Registration Statement on Form F-3 (the "Registration
Statement") filed on August 10, 2022 and the prospectus supplement to the Registration Statement. The Company will pay the Sales
Agent a commission amounting to 3.0% of the aggregate gross proceeds from the sale of Ordinary Shares. To date, 17,566 Ordinary Shares
have been sold, resulting in aggregate gross proceeds to the Company of $26.
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:
The principal accounting policies
adopted in the preparation of the financial statements are set out below. The policies have been consistently applied to all the years
presented, unless otherwise stated.
Basis of preparation
These interim condensed financial
statements have been prepared in accordance with the International Accounting Standards (the "IAS") 34 Interim Financial
Reporting, as issued by the International Accounting Standards Board (IASB). They do not include all disclosures that would otherwise
be required in a complete set of financial statements and should be read in conjunction with the 2022 annual financial statements filed
with the Company's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission on March 31, 2023. The Company
has applied the same accounting policies and methods of computation in its interim financial statements as in its 2022 annual financial
Impact of accounting standards to be applied in future periods
There are a number of standards and
interpretations which have been issued by the IAS board that are effective for periods beginning subsequent to December 31, 2023 (the
date through which the Company's next annual financial statements will be prepared up to) that the Company decided not to adopt
early. The Company does not believe these standards and interpretations will have a material impact on the financial statements once
A number of amended standards became
applicable for the current reporting period. The Company did not have to change its accounting policies or make retrospective adjustments
as a result of adopting these amended standards:
INSPIRA TECHNOLOGIES OXY B.H.N. LTD.
NOTES TO THE UNAUDITED INTERIM CONDENSED
FINANCIAL STATEMENTS